Find out how to tackle one of the biggest challenges in treating cancer with Genomic testing for cancer treatment Read more
You can view the latest news, articles and announcements on EndoPredict below or visit our official Eurobio Scientific News page.
Two prospective real-world studies presented at SABCS show EndoPredict® accurately guides decisions on chemotherapy in ER+, HER2- breast cancer 12th Decemb...
Should we use genetic signatures for chemotherapy decisions in ER+/HER2- premenopausal patients? Dr. Anastasia Constantinidou shares key new data from ESMO Con...
New publication shows EndoPredict Breast Cancer Prognostic Test accurately identified premenopausal women with ER+, HER2- breast cancer who could safely avoid ...
Clinicians demonstrated up to 100% adherence to EndoPredict test results in extended endocrine therapy decision making As a leader in genetic testing and ...